248 related articles for article (PubMed ID: 3927929)
1. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
Demol P; Wingender W; Weihrauch TR; Graefe KH
Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
[TBL] [Abstract][Full Text] [Related]
2. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
Guslandi M; Passaretti S; Tittobello A; Fasani R
Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
[TBL] [Abstract][Full Text] [Related]
3. Effect of rioprostil (16-methyl-prostaglandin-E1 analog) on gastric secretion in healthy volunteers.
Vaona B; Vantini I; Benini L; Brocco G; Chiarioni G; Scuro LA
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():328-33. PubMed ID: 2959074
[No Abstract] [Full Text] [Related]
4. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man.
Konturek SJ; Kwiecień N; Swierczek J; Oleksy J; Sito E; Robert A
Gastroenterology; 1976 May; 70(5 PT.1):683-7. PubMed ID: 770226
[TBL] [Abstract][Full Text] [Related]
6. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
8. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a capsule and tablet formulation.
Müller P; Dammann HG; Leucht U; Simon B
Arzneimittelforschung; 1989 Jul; 39(7):809-11. PubMed ID: 2783184
[TBL] [Abstract][Full Text] [Related]
9. Effect of 16, 16-dimethyl prostaglandin E2 methyl ester on gastric secretion induced by pentagastrin and pepton meal in man.
Swierczek J; Kwiecień N; Oleksy J; Konturek SJ
Acta Physiol Pol; 1976; 27(2):131-8. PubMed ID: 775888
[TBL] [Abstract][Full Text] [Related]
10. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
[TBL] [Abstract][Full Text] [Related]
11. Effects of misoprostol on histamine-related gastric secretion in man.
Wilson DE; Wilson PC
J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
[TBL] [Abstract][Full Text] [Related]
12. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
13. Effects of misoprostol on gastric pepsin secretion and human mucosal cell loss in man.
Quadros E; Wilson DE
J Assoc Acad Minor Phys; 1990; 1(2):17-9. PubMed ID: 2135692
[TBL] [Abstract][Full Text] [Related]
14. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a tablet and lyovial formulation.
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1987 Aug; 37(8):972-4. PubMed ID: 3675697
[TBL] [Abstract][Full Text] [Related]
15. The effects of rioprostil on gastric emptying and intragastric acidity.
Penston JG; Johnston DA; Wormsley KG
Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468
[TBL] [Abstract][Full Text] [Related]
16. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779
[TBL] [Abstract][Full Text] [Related]
17. Rioprostil and the gastric mucus-bicarbonate barrier.
Guslandi M; Fasani R; Tittobello A
Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
[TBL] [Abstract][Full Text] [Related]
18. Effect of trimoprostil on gastric secretion in man.
Ishimori A; Kawamura T; Koizumi F
Arzneimittelforschung; 1988 Jun; 38(6):833-9. PubMed ID: 3140824
[TBL] [Abstract][Full Text] [Related]
19. Effect of rioprostil, a synthetic prostaglandin E1 on meal-stimulated gastric acid secretion and plasma gastrin levels in humans.
Schulte K; Singer MV; Eysselein V; Demol P; Goebell H
Digestion; 1987; 36(3):162-7. PubMed ID: 3109990
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
